June 18, 2012
Merck KGaA, which includes Merck Serono under its umbrella, is considering entry into the Japanese biosimilars market. After having formed a collaborative agreement with leading Indian generics manufacturer Dr. Reddy’s Laboratories in the joint development, manufacture, and commercialization of biosimilars...read more